Cargando…

Effectiveness of REGEN-COV combination monoclonal antibody infusion to reduce the risk of COVID-19 hospitalization in pregnancy: a retrospective cohort study

Detalles Bibliográficos
Autores principales:	Williams, Frank B., Morgan, John A., Elmayan, Ardem, Martin, Jane K., Mussarat, Naiha, Biggio, Joseph R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2023
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464623/ https://www.ncbi.nlm.nih.gov/pubmed/36108732 http://dx.doi.org/10.1016/j.ajog.2022.09.017

Ejemplares similares

Timing of COVID-19 as a Predictor of Adverse Neonatal Outcomes
por: Mussarat, Naiha, et al.
Publicado: (2022)

Sociodemographic Determinants of COVID-19 Susceptibility and Outcomes in the Pregnant Population
por: Mussarat, Naiha, et al.
Publicado: (2022)

Effectiveness of REGEN-COV antibody combination to reduce risk of hospitalization for pregnant patients with COVID-19
por: F, Williams, et al.
Publicado: (2023)

Risk for stillbirth following maternal COVID-19 in otherwise low risk pregnancies
por: Puri, Priya M., et al.
Publicado: (2023)

Delivering Monoclonal Antibody Infusions to Novel Outpatient Settings
por: Minnich, Amy, et al.
Publicado: (2022)

Eptinezumab: A calcitonin gene-related peptide monoclonal antibody infusion for migraine prevention
por: Morgan, Kelsey Woods, et al.
Publicado: (2021)

759Fetal demise in the time of a pandemic: is there a correlation?
por: Combs, Abigail Lepsch, et al.
Publicado: (2021)

The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies
por: Copin, Richard, et al.
Publicado: (2021)

Clinical development methodology for infusion-related reactions with monoclonal antibodies
por: Doessegger, Lucette, et al.
Publicado: (2015)

The importance of early identification of infusion-related reactions to monoclonal antibodies
por: Cáceres, Macarena C, et al.
Publicado: (2019)

Reactions and COVID-19 disease progression following SARS-CoV-2 monoclonal antibody infusion
por: Goldin, Laurel, et al.
Publicado: (2021)

Acute bilateral angle closure induced by monoclonal antibody (Daratumumab) infusion
por: Saengsirinavin, Aim-on, et al.
Publicado: (2021)

Monoclonal Antibody Infusion Service for Obstetric Women Infected With COVID-19
por: Hiner, Jacqueline B., et al.
Publicado: (2022)

Acute low back pain as infusion-related reaction to monoclonal antibodies
por: Majenka, Pawel, et al.
Publicado: (2023)

Novel infusion strategy reduces severe adverse events caused by the anti-GD2 monoclonal antibody naxitamab
por: Varo, Amalia, et al.
Publicado: (2023)

532. Establishing a SARS-CoV-2 Monoclonal Antibody Infusion Clinic: Early Trends in Outcomes and Disparities
por: Hare, Allison J, et al.
Publicado: (2021)

High prevalence of Trypanosoma cruzi infection in shelter dogs from southern Louisiana, USA
por: Elmayan, Ardem, et al.
Publicado: (2019)

Systematic Review on Infusion Reactions Associated with Chemotherapies and Monoclonal Antibodies for Metastatic Colorectal Cancer
por: Song, Xue, et al.
Publicado: (2011)

More Accessible COVID-19 Treatment Through Monoclonal Antibody Infusion in the Emergency Department
por: Heinert, Sara W., et al.
Publicado: (2022)

Standing-up COVID-19 monoclonal antibody infusion centers: Infection prevention and control
por: Brewer, Brooke, et al.
Publicado: (2023)

Feasibility and impact of a monoclonal antibody infusion program in reaching vulnerable underserved communities
por: Mena Lora, Alfredo J., et al.
Publicado: (2023)

The use and impact of monoclonal antibody biologics during pregnancy
por: Pham-Huy, Anne, et al.
Publicado: (2021)

REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19
por: Weinreich, David M., et al.
Publicado: (2021)

Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19
por: O’Brien, Meagan P., et al.
Publicado: (2021)

Subcutaneous REGEN-COV Antibody Combination for Covid-19 Prevention
por: O’Brien, Meagan P., et al.
Publicado: (2021)

Subcutaneous REGEN-COV antibody administration in a community pharmacy
por: Dougherty, Tyler S., et al.
Publicado: (2023)

Monoclonal antibody infusion for COVID-19 infection: results from a tertiary referral center
por: Voelker, Dayne, et al.
Publicado: (2022)

Genetic diversity of Trypanosoma cruzi parasites infecting dogs in southern Louisiana sheds light on parasite transmission cycles and serological diagnostic performance
por: Dumonteil, Eric, et al.
Publicado: (2020)

Reduced sensitivity of the SARS-CoV-2 Lambda variant to monoclonal antibodies and neutralizing antibodies induced by infection and vaccination
por: Wang, Meiyu, et al.
Publicado: (2021)

Treatment of COVID-19 with monoclonal antibodies casirivimab and imdevimab in pregnancy
por: Folkman, Rebecca, et al.
Publicado: (2022)

Human monoclonal antibodies and monoclonal antibody multispecificity.
por: Campbell, A. M., et al.
Publicado: (1987)

Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Infusions in High-Risk Outpatients
por: Piccicacco, Nicholas, et al.
Publicado: (2021)

Monoclonal Antibody for Reducing Memory and Learning Problems in Schizophrenia
por: Akhondzadeh, Shahin
Publicado: (2018)

Staffing and Capacity Planning for SARS-CoV-2 Monoclonal Antibody Infusion Facilities: A Performance Estimation Calculator Based on Discrete-Event Simulations
por: Çaglayan, Çaglar, et al.
Publicado: (2022)

Emerging SARS-CoV-2 variants reduce neutralization sensitivity to convalescent sera and monoclonal antibodies
por: Hu, Jie, et al.
Publicado: (2021)

A human monoclonal antibody blocking SARS-CoV-2 infection
por: Wang, Chunyan, et al.
Publicado: (2020)

Identification of a Monoclonal Antibody That Attenuates Antiphospholipid Syndrome-Related Pregnancy Complications and Thrombosis
por: Mineo, Chieko, et al.
Publicado: (2016)

REGEN‐COV antibody combination in patients with lymphoproliferative malignancies and SARS‐CoV‐2 infection
por: Bronstein, Yotam, et al.
Publicado: (2022)

Monoclonal antibody infusion reaction with bamlanivimab and etesevimab in a 5-year-old male with coronavirus disease 2019: a case report
por: Pillai, Rajapillai L. I., et al.
Publicado: (2023)

Effectiveness of REGEN-COV antibody combination in preventing severe COVID-19 outcomes
por: Hayek, Samah, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e6vnnej34gtjli7viatu63qneb